Kingsway Signs $7.9M Definitive Purchase Agreement to Acquire National Institute of Clinical Research, Inc.

Kingsway Financial Services Inc. (“Kingsway” or the “Company”) has announced the signing of a definitive agreement to purchase 95% of the shares of National Institute of Clinical Research, Inc. (“NICR”), a provider of clinical trial site management and recruitment services for nephrology, cardiometabolic, infectious diseases and gastroenterology. NICR participates in the development of innovative and life-saving therapies through its dedication to and focus on clinical research. NICR combines the use of the latest technologies, streamlined clinical operations, and extensive access to a diverse population to deliver the highest quality clinical trials for life-changing therapies.

Read the full article: Kingsway Signs $7.9M Definitive Purchase Agreement to Acquire National Institute of Clinical Research, Inc. //

Source: https://www.accesswire.com/795336/kingsway-signs-79-million-definitive-purchase-agreement-to-acquire-national-institute-of-clinical-research-inc

Leave a Comment

Your email address will not be published.

Scroll to Top